Logo image
Sign in
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
Journal article   Open access  Peer reviewed

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Luis M Ruilope, Rajiv Agarwal, Stefan D Anker, George L Bakris, Gerasimos Filippatos, Christina Nowack, Peter Kolkhof, Amer Joseph, Nicole Mentenich, Bertram Pitt, …
2019

Abstract

Aldosterone ANTAGONIST BAY 94-8862 CHRONIC HEART-FAILURE Clinical COMPLICATIONS Diabetes EFFICACY Kidney Medicine and Health Sciences MILD MINERALOCORTICOID Outcomes RECEPTOR RISK SPIRONOLACTONE WORSENING RENAL-FUNCTION
url
https://doi.org/10.1159/000503712View
Published (Version of record) Open

Details